Replies to post #437843 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

The ALZ-801 precision medicine development approach, is interesting. Unfortunately, a private company (still), which I otherwise would have taken a position in.

Their P3 trial is also of the proper duration in Early AD, whereas in just 48 weeks it is especially hard to show clear separation vs. placebo.